David E Thaler MD PhD, FAHA

PubMed

• 1 citations
  PFO Device Closure in Patients >60 Years of Age With Ischemic Stroke: Results From U.S. Medicare Beneficiaries.
  Ruby Satpathy, Josep Rodés-Cabau, David E Thaler, David M Kent, Samuel Turner
  JACC. Cardiovascular Interventions. 2025-05-26
• 16 citations
  5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.
  Dhanunjaya Lakkireddy, Christopher R Ellis, David Thaler, Vijendra Swarup, Alok Gambhir
  Journal of the American College of Cardiology. 2025-03-25
• 4 citations
  Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial Feasibility.
  Andy Y Wang, Peter M Rothwell, Jason Nelson, Jeffrey L Saver, Scott E Kasner
  Neurology. 2024-05-28

Journal Articles

• Patient Selection for PFO Closure Based on the RoPE Study  
  Thaler DE, Cardiac Interventions Today, 1/1/2014
• Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs  
  Thaler DE, Ruthazer R, Weimar C. et. al., Neurology, 1/1/2014
• Association of Ischemic Stroke, Hormone Therapy, and Right to Left Shunt in Postmenopausal Women  
  NC, Liebeskind DS, Gevorgyan R, Truong T, Cua B, Tseng C, Dodick DW, Demaerschalk BM, Thaler DE, Tobis JM, Catheterization and Cardiovascular Interventions, 1/1/2014

Books/Book Chapters

• Imaging Cerebrovascular Disease 
  Chapter: Cerebral infarction during its subacute stage 
  Thaler DE, Sloan MA, Babikian VLEditors: Babikian VL, Wechsler LR, Higashida RT.Butterworth-Heinemann, Philadelphia, PA2003
• Oxford Handbook of Clinical Medicine: American Edition 
  Thaler D, Longmore M, and Hope ROxford University Press1999

Abstracts/Posters

• Anticoagulation versus Antiplatelet Therapy in Patients with Cryptogenic Stroke and Patent Foramen Ovale: An Adjusted Individual Patient Data and RoPE Score-Stratified...
  Kent DM, Dahabreh IJ, Ruthazer R, Furlan A, Weimar C, Serena J, Meier B, Mattle HP, Di Angelantonio E, Paciaroni M, Schuchlenz H, Homma S, Jaigobin C, Lutz JS, Thaler DE, European Stroke Conference, Nice, France, 1/1/2014
• Predictors Differ in Patients With ‘Probable Pathogenic’ Versus Other PFOs
  Thaler DE, Ruthazer R, Angelantonio ED, Di Tullio MR, Donovan JS, Elkind MS, Griffith J, Homma S, Jaigobin C, Mas JL, Mattel HP, Michel P, Mono ML, Nedeltchev K, Papet..., International Stroke Conference, Honolulu, HI, 1/1/2013
• An Analysis of ‘High Risk’ Features on Transesophageal Echocardiography in the Risk of Paradoxical Embolism Database
  Wessler B, Thaler DE, Di Tullio MR, Ruthazer R, Weimar C, Mas JL, Serena J, Angelantonio ED, Donovan JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono M..., International Stroke Conference, Honolulu, HI, 1/1/2013

Lectures

• PFOs should be closed in patients with cryptogenic stroke 
  Copenhagen, Denmark - 1/1/2014
• PFO and Stroke: Let me show you the RoPE 
  Massachusetts General Hospital Stroke Service, Boston, MA - 1/1/2014
• Spinal Manipulation therapy and arterial dissection 
  Boston, MA - 1/1/2014

Other

• Supplementary Motor Cortex and the Control of Action 
  Thaler D
  1/1/1988
• Differing Predictors for Recurrent Stroke Among Treated Patients With Possible Incidental PFO 
  Thaler DE, PracticeUpdate website
  http://www.practiceupdate.com/journalscan/11250
  1/12/2014